We've merged with Palleos Healthcare to form a wide-reaching European CRO.
Find out more
The CNS Summit community is composed of more than 1,000 curated decision makers involved in clinical development and commercialization, healthcare innovation and regulatory authorities, patient advocates, investors and other stakeholders. Members are ambitious, visionary, innovative and focused on a better future.
OCT Clinical will be represented at the event by Anna Lineva, Director, Business Development. Book a meeting with OCT team to discuss your clinical trial options for your neurology study at alineva@oct-clinicaltrials.com.
OCT Clinical is now operating under Palleos Healthcare brand name.
“The merger will undoubtedly create significant synergies, not just doubling but squaring the expertise of both companies”, Philip Räth, Ph.D., managing director at Palleos, said in the release.
“OCT Clinical is proud to join forces with palleos healthcare, as it has an excellent reputation in the industry it serves. Now we can offer tailored solutions to our clients to meet their diverse clinical research needs and accelerate the time of bringing their products to market”, Dmitry Sharov, CEO at OCT Clinical.